ALKERMES | Ventes

Sales Changement Date
AbbVie USD 14.3B 374M 2023-12
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
ALKERMES USD 377.48M 3.46M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
Intra Cellular Therapies USD 132.1M 5.93M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
J&J USD 21.38B 15M 2024-03
Malin Corporation EUR 19.2M 2.6M 2020-12
Merck USD 14.63B 1.33B 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Otsuka Holdings JPY 539.49B 7.94B 2023-12
Pfizer USD 14.25B 1.02B 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



ALKERMES Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.